Share your experience with our expert service team!
Take a short survey here.
The Cardiogenesis holmium:YAG laser is a Class III PMA cardiovascular therapeutic device that is designed to deliver precise energy output for the desired tissue effect. Cardiogenesis recommends factory trained & certified manufacturer service support to ensure the laser is operating within the critical factory specifications and to protect our customer’s investment.
The solid state technology of the Cardiogenesis holmium:YAG laser system (Solargen 2100s, TMR 2000) provides a stable and reliable energy platform. As a Class III PMA cardiovascular therapeutic device, Cardiogenesis recommends that the system be calibrated and maintained by a factory certified service engineer at least twice a year.
Cardiogenesis factory trained and certified service engineers provide responsive preventive and corrective maintenance in support of your TMR program. Our service engineers will document and certify the calibration and operation of your Cardiogenesis TMR laser system to factory specifications upon completion of each service action. The documentation provided will meet JACHO requirements.
The following service program offerings are intended to provide a range of choices in meeting the service support needs of all of our customers. Our goal is to assist you in ensuring your investment in the Cardiogenesis TMR system is maintained and calibrated within factory specifications, and to minimize your exposure to any potential repair costs and system down time.
One Year Maintenance and Full Service Warranty Program
The One Year Maintenance and Full Service Warranty Program includes: two scheduled system calibration and maintenance actions; no charge parts replacement and repair labor; rapid emergency response; any and all costs associated with maintaining the Cardiogenesis holmium:YAG TMR system within manufacturer’s specifications as required due to normal and reasonable operation and handling of the system. Pricing valid for for continental USA only.
Cardiogenesis Corporation is a cardiovascular device company innovating new treatments for cardiovascular disease and a leader in therapies designed to stimulate cardiac angiogenesis (new blood vessel formation) and aid in revascularization of patients with ischemic heart disease. The company’s market leading holmium:YAG laser and fiber optic delivery systems are used to treat patients suffering from the debilitating pain of severe angina.
24-Hour Technical Support: 800.741.7062